Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

VOR US Equity

Vor Biopharma Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1817229 · FY ends Dec 31
$23.58
+0.30 (+1.29%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 1 13D · 6 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Venrock Healthcare Capital Partners III, L.P.sec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Frazier Life Sciences Public Fund, L.P.sec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Verve Capital Ltdsec.gov ↗
2026-08-0713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-08-0613GSchedule 13G filed — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-07-3013GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-2113D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2026-07-078-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-07

Every row is a filed document, checked against its EDGAR index.